Literature DB >> 25818655

Rhes regulates dopamine D2 receptor transmission in striatal cholinergic interneurons.

Giuseppe Sciamanna1, Francesco Napolitano2, Barbara Pelosi3, Paola Bonsi4, Daniela Vitucci5, Tommaso Nuzzo6, Daniela Punzo6, Veronica Ghiglieri7, Giulia Ponterio1, Massimo Pasqualetti8, Antonio Pisani9, Alessandro Usiello10.   

Abstract

Ras homolog enriched in striatum (Rhes) is highly expressed in striatal medium spiny neurons (MSNs) of rodents. In the present study, we characterized the expression of Rhes mRNA across species, as well as its functional role in other striatal neuron subtypes. Double in situ hybridization analysis showed that Rhes transcript is selectively localized in striatal cholinergic interneurons (ChIs), but not in GABAergic parvalbumin- or in neuropeptide Y-positive cell populations. Rhes is closely linked to dopamine-dependent signaling. Therefore, we recorded ChIs activity in basal condition and following dopamine receptor activation. Surprisingly, instead of an expected dopamine D2 receptor (D2R)-mediated inhibition, we observed an aberrant excitatory response in ChIs from Rhes knockout mice. Conversely, the effect of D1R agonist on ChIs was less robust in Rhes mutants than in controls. Although Rhes deletion in mutants occurs throughout the striatum, we demonstrate that the D2R response is altered specifically in ChIs, since it was recorded in pharmacological isolation, and prevented either by intrapipette BAPTA or by GDP-β-S. Moreover, we show that blockade of Cav2.2 calcium channels prevented the abnormal D2R response. Finally, we found that the abnormal D2R activation in ChIs was rescued by selective PI3K inhibition thus suggesting that Rhes functionally modulates PI3K/Akt signaling pathway in these neurons. Our findings reveal that, besides its expression in MSNs, Rhes is localized also in striatal ChIs and, most importantly, lack of this G-protein, significantly alters D2R modulation of striatal cholinergic excitability.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Calcium; Cholinergic interneurons; D2 dopamine receptors; Dystonia; Rhes; Striatum

Mesh:

Substances:

Year:  2015        PMID: 25818655     DOI: 10.1016/j.nbd.2015.03.021

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  11 in total

1.  Diverse Mechanisms Lead to Common Dysfunction of Striatal Cholinergic Interneurons in Distinct Genetic Mouse Models of Dystonia.

Authors:  Karen L Eskow Jaunarajs; Mariangela Scarduzio; Michelle E Ehrlich; Lori L McMahon; David G Standaert
Journal:  J Neurosci       Date:  2019-07-18       Impact factor: 6.167

Review 2.  Probing striatal microcircuitry to understand the functional role of cholinergic interneurons.

Authors:  Allison E Girasole; Alexandra B Nelson
Journal:  Mov Disord       Date:  2015-07-30       Impact factor: 10.338

3.  Rasd2 Modulates Prefronto-Striatal Phenotypes in Humans and 'Schizophrenia-Like Behaviors' in Mice.

Authors:  Daniela Vitucci; Annabella Di Giorgio; Francesco Napolitano; Barbara Pelosi; Giuseppe Blasi; Francesco Errico; Maria Teresa Attrotto; Barbara Gelao; Leonardo Fazio; Paolo Taurisano; Anna Di Maio; Valentina Marsili; Massimo Pasqualetti; Alessandro Bertolino; Alessandro Usiello
Journal:  Neuropsychopharmacology       Date:  2015-07-31       Impact factor: 7.853

4.  Profile of pridopidine and its potential in the treatment of Huntington disease: the evidence to date.

Authors:  Ferdinando Squitieri; Justo Garcia de Yebenes
Journal:  Drug Des Devel Ther       Date:  2015-10-28       Impact factor: 4.162

5.  Decreased Rhes mRNA levels in the brain of patients with Parkinson's disease and MPTP-treated macaques.

Authors:  Francesco Napolitano; Emily Booth Warren; Sara Migliarini; Daniela Punzo; Francesco Errico; Qin Li; Marie-Laure Thiolat; Angelo Luigi Vescovi; Paolo Calabresi; Erwan Bezard; Micaela Morelli; Christine Konradi; Massimo Pasqualetti; Alessandro Usiello
Journal:  PLoS One       Date:  2017-07-25       Impact factor: 3.240

6.  Early structural and functional plasticity alterations in a susceptibility period of DYT1 dystonia mouse striatum.

Authors:  Fabrizio Gardoni; Antonio Pisani; Marta Maltese; Jennifer Stanic; Annalisa Tassone; Giuseppe Sciamanna; Giulia Ponterio; Valentina Vanni; Giuseppina Martella; Paola Imbriani; Paola Bonsi; Nicola Biagio Mercuri
Journal:  Elife       Date:  2018-03-05       Impact factor: 8.140

7.  MicroRNA-101 inhibits the expression of Rhes, a striatal-enriched small G-protein, at the post-transcriptional level in vitro.

Authors:  Hideya Mizuno; Ayako Taketomi
Journal:  BMC Res Notes       Date:  2018-07-31

Review 8.  Involvement of the Protein Ras Homolog Enriched in the Striatum, Rhes, in Dopaminergic Neurons' Degeneration: Link to Parkinson's Disease.

Authors:  Marcello Serra; Annalisa Pinna; Giulia Costa; Alessandro Usiello; Massimo Pasqualetti; Luigi Avallone; Micaela Morelli; Francesco Napolitano
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

9.  Rhes Counteracts Dopamine Neuron Degeneration and Neuroinflammation Depending on Gender and Age.

Authors:  Giulia Costa; Annalisa Pinna; Pier Francesca Porceddu; Maria Antonietta Casu; Anna Di Maio; Francesco Napolitano; Alessandro Usiello; Micaela Morelli
Journal:  Front Aging Neurosci       Date:  2018-05-31       Impact factor: 5.750

10.  The striatal-enriched protein Rhes is a critical modulator of cocaine-induced molecular and behavioral responses.

Authors:  Francesco Napolitano; Arianna De Rosa; Rosita Russo; Anna Di Maio; Martina Garofalo; Mauro Federici; Sara Migliarini; Ada Ledonne; Francesca Romana Rizzo; Luigi Avallone; Tommaso Nuzzo; Tommaso Biagini; Massimo Pasqualetti; Nicola Biagio Mercuri; Tommaso Mazza; Angela Chambery; Alessandro Usiello
Journal:  Sci Rep       Date:  2019-10-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.